News

Public · Published

Oppenheimer flags 16 Buys outside the AI trade as S&P 500 stalls near highs

Oppenheimer Asset Management named 16 Buy-rated stocks in software, commercial services, and insurance, while the S&P 500 sits just below its all-time high. The firm said investor focus has rotated away from pure AI plays toward non-AI exposure over the past two weeks.

Published:

Updated:

What happened

Oppenheimer Asset Management named 16 Buy-rated stocks in software, commercial services, and insurance, while the S&P 500 sits just below its all-time high. The firm said investor focus has rotated away from pure AI plays toward non-AI exposure over the past two weeks.

Confirmed

Global impact / market context

The list shows where Oppenheimer sees opportunities if money keeps moving out of crowded AI stocks. Software, services, and insurance companies earn revenue from subscriptions, contracts, and premiums, so a bounce there could support investor returns even when AI leadership fades.

Analyst inference

Oppenheimer flags growing numbers of broken intermediate uptrends, which means shorter-term price rises have failed. It warns any year-end advance may lack confirmation from market breadth, leadership, and credit markets, where market breadth means how widely stocks are rising.

Analyst inference

What to watch

  1. Oppenheimer named specific Buy-rated stocks, including C3.AI, Bentley Systems, HubSpot, Kyndryl, MicroStrategy, Q2 Holdings, Tyler Technologies, Wix.com, Broadridge, Cintas, Republic Services, Verisk, Arthur J. Gallagher, MetLife, Progressive, and Travelers. Confirmed
  2. Oppenheimer suggests a near-term relief bounce is likely, but expects gains in the most oversold segments to stall near their 200-day moving averages, which are average prices over 200 trading days, until a deeper reset unfolds. Proposed
  3. Investors should watch whether non-AI software, commercial services, and insurance stocks attract steady buying rather than a short bounce, since Oppenheimer says a durable advance needs broader participation across stock groups. Analyst inference

Evidence